title: Risk factors and options to improve engraftment in unrelated cord blood transplantation.
abstract: Use of umbilical unrelated cord-blood (UCB) cells as an alternative source of hematopoietic cell transplantation has been widely used mainly for patients lacking an HLA-matched donor. UCB present many advantages over bone marrow or mobilized peripheral blood from volunteer donors, such as rapid availability, absence of risk for the donor, and decreased incidence of acute graft-versus-host disease. However, a significant clinical problem is delayed engraftment that is directly correlated with the number of hematopoietic stem cells in a cord-blood unit. The identification of prognostic factors associated with engraftment that can be easily modified (e.g., strategies for donor choice) and the development of new approaches including use of multiple donors, intrabone injection of UCB, ex vivo expansion, and cotransplantation with accessory cells are of crucial importance in order to circumvent the problem of delayed engraftment after UCB transplantation. Those approaches may increase the quality and availability of UCB for transplantation.
authors: Université de Paris 7, Hospital Saint-Louis, 1, Avenue Claude Vellefaux, 75010 Paris, France.
authors: Anna D
authors: AD
authors: Petropoulou
authors: Vanderson
authors: V
authors: Rocha
references: Blood. 2003 Mar 15;101(6):2137-43
references: 12424197
references: Blood. 2005 Feb 1;105(3):1343-7
references: 15466923
references: Blood. 2005 Oct 15;106(8):2693-9
references: 15976178
references: Cytotherapy. 2009;11(3):278-88
references: 19308773
references: Bone Marrow Transplant. 2009 Mar;43(6):447-54
references: 18955980
references: Nat Med. 2010 Feb;16(2):232-6
references: 20081862
references: Br J Haematol. 2007 May;137(3):248-51
references: 17408466
references: Br J Haematol. 2009 Oct;147(2):161-76
references: 19796265
references: Bone Marrow Transplant. 2008 May;41(9):771-8
references: 18209724
references: Br J Haematol. 2001 Jul;114(1):42-8
references: 11472343
references: Lancet Oncol. 2008 Sep;9(9):831-9
references: 18693069
references: Blood. 2001 May 15;97(10):2962-71
references: 11342418
references: Biol Blood Marrow Transplant. 2007 Jan;13(1):82-9
references: 17222756
references: Blood. 2001 Oct 15;98(8):2332-8
references: 11588027
references: Leukemia. 2014 Apr;28(4):779-86
references: 24005245
references: J Clin Oncol. 2009 Jan 10;27(2):256-63
references: 19064984
references: Exp Hematol. 2004 Aug;32(8):782-7
references: 15308330
references: Blood. 2007 Oct 15;110(8):3064-70
references: 17569820
references: Exp Hematol. 2003 Jun;31(6):535-44
references: 12829030
references: Bone Marrow Transplant. 2008 Jan;41(2):207-14
references: 18084331
references: N Engl J Med. 1998 Nov 26;339(22):1565-77
references: 9828244
references: Blood. 2009 Feb 19;113(8):1631-8
references: 19104080
references: Blood. 2008 Nov 15;112(10):4318-27
references: 18723429
references: N Engl J Med. 2004 Nov 25;351(22):2265-75
references: 15564543
references: Blood. 2003 Sep 1;102(5):1915-9
references: 12738676
references: Bone Marrow Transplant. 2009 Mar;43(5):365-73
references: 18850019
references: Br J Haematol. 2008 Nov;143(3):404-8
references: 18699847
references: Blood. 2002 Sep 1;100(5):1611-8
references: 12176879
references: Haematologica. 2006 Feb;91(2):223-30
references: 16461307
references: Bone Marrow Transplant. 2009 Nov;44(10):627-33
references: 19802026
references: Blood. 2010 Nov 25;116(22):4693-9
references: 20686119
references: Blood. 2007 Apr 15;109(8):3579-87
references: 17213287
references: Exp Hematol. 2004 Apr;32(4):397-407
references: 15050751
references: Blood. 2004 Dec 1;104(12):3813-20
references: 15280199
references: Curr Opin Hematol. 2004 Nov;11(6):375-85
references: 15548991
references: Science. 2004 Aug 13;305(5686):1000-3
references: 15310902
references: Blood. 2007 Dec 15;110(13):4543-51
references: 17671230
references: Stem Cells Dev. 2007 Jun;16(3):347-54
references: 17610364
references: Blood. 2009 Nov 5;114(19):4293-9
references: 19706886
references: Blood. 2010 Mar 4;115(9):1843-9
references: 20029048
references: Lancet. 2007 Jun 9;369(9577):1947-54
references: 17560447
references: N Engl J Med. 2000 Jun 22;342(25):1846-54
references: 10861319
references: N Engl J Med. 2004 Nov 25;351(22):2276-85
references: 15564544
references: Biol Blood Marrow Transplant. 2007 Sep;13(9):1073-82
references: 17697970
references: N Engl J Med. 1997 Aug 7;337(6):373-81
references: 9241126